(Q85049429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Lack of a clinically meaningful pharmacokinetic effect of rifabutin on raltegravir: in vitro/in vivo correlation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation (English)

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

16 July 2024

1 reference

1 reference

1 reference

Kelem Kassahun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Chengcheng Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jared Lunceford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Niresh Hariparsad

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Roy Eisenhandler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Alisha Norcross

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Marian Iwamoto

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Diana M. Brainard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20852006

16 July 2024

Larissa A. Wenning

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20852006

16 July 2024

Amelia S. Petry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20852006

16 July 2024

Emanuel P. DeNoia

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20852006

16 July 2024

Julie A. Stone

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20852006

16 July 2024

John A. Wagner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20852006

16 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20852006

16 July 2024

publication date

17 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 February 2020

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270010375959

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

https://onlinelibrary.wiley.com/doi/full/10.1177/0091270010375959

16 July 2024

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

The Journal of Clinical Pharmacology

16 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

943-950

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

14 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

16 July 2024

3

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

16 July 2024

4

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

16 July 2024

6

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

16 July 2024

7

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

16 July 2024

9

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Raltegravir with optimized background therapy for resistant HIV-1 infection

16 July 2024

10

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

16 July 2024

11

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

16 July 2024

12

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection

16 July 2024

13

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir

16 July 2024

14

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin

16 July 2024

19

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive

16 July 2024

20

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Tuberculosis in patients with human immunodeficiency virus infection

16 July 2024

21

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Treatment Options for HIV-Associated Tuberculosis

16 July 2024

22

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects.

16 July 2024

23

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Induction of theophylline clearance by rifampin and rifabutin in healthy male volunteers.

16 July 2024

24

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid–liquid extraction and HPLC-MS/MS

16 July 2024

25

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Indinavir and rifabutin drug interactions in healthy volunteers

16 July 2024

26

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies

16 July 2024

27

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes.

16 July 2024

28

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Therapeutic drug monitoring in the treatment of HIV-infection

16 July 2024

29

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation

16 July 2024

32

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects

16 July 2024

33

1 reference

https://api.crossref.org/works/10.1177/0091270010375959

16 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852006%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference